| For: | Zu GX, Sun KY, Liu XJ, Tang JQ, Huang HL, Han T. Banxia xiexin decoction prevents the development of gastric cancer. World J Clin Oncol 2024; 15(10): 1293-1308 [PMID: 39473858 DOI: 10.5306/wjco.v15.i10.1293] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i10/1293.htm |
| Number | Citing Articles |
| 1 |
Xiao Liang, Liu Yang, Yueshan Zhang, Shuaiqi Yuan, Yonggui Hong. Integrative management of gastric cardia cancer and precancerous lesions: prospects and mechanistic rationale for Banxia Xiexin Tang. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1763396
|
| 2 |
Lujia Chen, Guonong He, Hongfei Liu. Autophagy-centered regulation of PI3K/Akt/mTOR and MAPK signaling by traditional Chinese medicine in gastric cancer. Tissue and Cell 2026; 101 doi: 10.1016/j.tice.2026.103409
|
| 3 |
Naserddine Hamadi, Suhail Al-Salam, Sumaya Beegam, Nur Elena Zaaba, Ozaz Elzaki, Abderrahim Nemmar. Chronic Exposure to Two Regimens of Waterpipe Smoke Elicits Lung Injury, Genotoxicity, and Mitochondrial Impairment with the Involvement of MAPKs Activation in Mice. International Journal of Molecular Sciences 2025; 26(1) doi: 10.3390/ijms26010430
|
| 4 |
Ruochen Li, Haotian Gao, Mingxiao Wang, Yong Zhang. Ginkgetin inhibits non-small cell lung cancer via the HSP90-AKT signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(7) doi: 10.1007/s00210-026-05072-8
|
| 5 |
Kun Lian, Lichong Meng, Junxian Lei, Huifang Kuang, Songyan Tie, Lin Li, Zhixi Hu. Visual analysis of research status and hotspots of Pinellia ternata from 2004 to 2025: A bibliometric review. Medicine 2026; 105(27) doi: 10.1097/MD.0000000000049572
|
| 6 |
Huimin Yang, Yanxia Ji, Yingzhe Ju, Yingying Shen, Xiaoyi Sun, Kaili Dai. FAM49B mediates tumor progression and poor prognosis of gastric cancer through activating PI3K/AKT pathway. Journal of Molecular Histology 2025; 56(5) doi: 10.1007/s10735-025-10589-y
|
| 7 |
Donghan Xu, Ziqing Lin, Lu Deng, Xiaonan Lu, Ziyi Guo, Peiyu Yan, Yehao Luo. Banxia xiexin decoction and its bioactive metabolites: multi-targeted mechanisms for suppressing gastric cancer progression, reversing chemoresistance, and remodeling the tumor microenvironment. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1810848
|
| 8 |
Chang Liu, Pengwei Gao, Xiaoying Liu, Min Kuang, Haoran Xu, Yangming Wu, Wenjun Liu, Shengpeng Wang. Reunderstanding the classical prescription Banxia Xiexin Decoction: new perspectives from a comprehensive review of clinical research and pharmacological studies. Chinese Medicine 2025; 20(1) doi: 10.1186/s13020-025-01087-0
|